NL-OMON50758招募中不适用
Sickle Cell Disease: Targeting Alloantibody formation Reduction; RIsk factors, aNd Genetics - STARRING
Sanquin Bloedbank0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •Sickle Cell disease patient
- •Need for transfusion
- •No alloantibodies
排除标准
- •>25 transfusions
- •Chronic transfusion scheme
研究者
相似试验
已完成
不适用
Sickle Cell Disease: Targeting Alloantibody formation Reduction (STAR) - Risk factors for alloantibody formatioAlloimmunisation in blood transfusion recipientsFormation of antibodies against foreign red blood cells after blood transfusion10018902NL-OMON41526Academisch Medisch Centrum300
Unknown
不适用
Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and GeneticsAlloimmunizationSickle Cell DiseaseNCT03288012Sanquin Research & Blood Bank Divisions150
招募中
不适用
Sickle Cell Outcome ResearchSickle cell diseaseNL-OMON29491A1,000
招募中
不适用
Sickle Cell Outcome REsearchSickle cell DiseaseNL-OMON55241Erasmus MC, Universitair Medisch Centrum Rotterdam1,000
尚未招募
不适用
Acetylcysteine for Treatment of Sickle Cell Diseasesickle cell disease10018902NL-OMON30544Academisch Medisch Centrum10